Schedule III [21 CFR 1308.13]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
Effective 13 Nov 1973, 38 FR 31310 renumbered:
(c)
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
(1)
Any compound, mixture or preparation containing:
Effective 31 Dec 1969, replacement for:
Effective 13 Nov 1973, 38 FR 31310 added (and renumbered subsequent entries):
Any compound, mixture or preparation containing Amobarbital, Secobarbital, Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
(i)
2126
Amobarbital
CA: CDSA Schedule IV Section 1 Subsection 3 Amobarbital
UN: Psychotropics Schedule III Amobarbital
See also CSA Schedule II Section e Subsection 1 Amobarbital and Schedule III Section c Subsection 2 Item i Amobarbital
(ii)
2316
Secobarbital
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
UN: Psychotropics Schedule II Secobarbital
See also CSA Schedule II Section e Subsection 5 Secobarbital and Schedule III Section c Subsection 2 Item ii Secobarbital
⇒
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
(iii)
2271
Pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
UN: Psychotropics Schedule III Pentobarbital
See also CSA Schedule II Section e Subsection 3 Pentobarbital and Schedule III Section c Subsection 2 Item iii Pentobarbital
⇒
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital(2)
Any suppository dosage form containing:
Effective 31 Dec 1969, replacement for:
Effective 13 Nov 1973, 38 FR 31310 added (and renumbered subsequent entries):
Any suppository dosage form containing containing Amobarbital, Secobarbital, Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
(i)
2126
Amobarbital
CA: CDSA Schedule IV Section 1 Subsection 3 Amobarbital
UN: Psychotropics Schedule III Amobarbital
See also CSA Schedule II Section e Subsection 1 Amobarbital and Schedule III Section c Subsection 1 Item i Amobarbital
(ii)
2316
Secobarbital
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
UN: Psychotropics Schedule II Secobarbital
See also CSA Schedule II Section e Subsection 5 Secobarbital and Schedule III Section c Subsection 1 Item ii Secobarbital
⇒
PubChem: 5193; ChemSpider: 5005; Bluelight: Secobarbital bioavailability; Drugs Forum: Secobarbital; Erowid: Barbiturates; Wikipedia: Secobarbital
(iii)
2271
Pentobarbital or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
UN: Psychotropics Schedule III Pentobarbital
See also CSA Schedule II Section e Subsection 3 Pentobarbital and Schedule III Section c Subsection 1 Item iii Pentobarbital
⇒
PubChem: 4737; ChemSpider: 4575; Bluelight: Pentobarbital; Drugs Forum: Pentobarbital; Erowid: Barbiturates; Wikipedia: Pentobarbital
(3)
2100
Any substance which contains any quantity of a derivative of Barbituric acid or any salt thereof
Effective 13 Nov 1973, 38 FR 31310 replacement for:
Any substance which contains any quantity of a derivative of Barbituric acid, or any salt of a derivative of Barbituric acid.
CA: CDSA Schedule IV Section 1 Subsection 6 Barbituric acid
Effective 28 Sep 2006, 71 FR 51115 added (and renumbered subsequent entries):
On 29 Aug 2005, 70 FR 50996 extended the comment period of the earlier proposal to 28 Sept 2005 from 29 Aug 2005
On 29 Jul 2005, 70 FR 43809 proposed to add (and to renumber subsequent entries):
(5)
2020
Embutramide
Effective 21 Mar 1991, 56 FR 11930 revoked (and renumbered subsequent entries):
2550
Glutethimide
US: Currently at CSA Schedule II Section e Subsection 2 Glutethimide
Effective 3 Apr 2000, 65 FR 17440 corrected an error in amendatory instruction 3 of 68 FR 13235
Effective 13 Mar 2000, 65 FR 13235 added (and renumbered subsequent entries):
(6)
2012
Any drug product containing Gamma-hydroxybutyric acid (GHB; Gamma-hydroxybutyrate; 4-Hydroxybutyrate; 4-Hydroxybutanoic acid; Sodium oxybate; Sodium oxybutyrate), including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
See also CSA Schedule I Section e Subsection 1 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 12 Aug 1999, 64 FR 37673 added:
On 9 Apr 1999, 64 FR 17299 proposed to add:
(7)
7285
Ketamine ((±)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone), its salts, isomers, and salts of isomers
(8)
7300
Lysergic acid
CA: CDSA Schedule VI Part 1 Subsection 8 Lysergic acid
EU: Drug precursors Annex I Category 1 Lysergic acid
UK: MDA Drug precursors Annex I Category 1 Lysergic acid
UN: Precursors Table I Lysergic acid
(10)
2575
Methyprylon
CA: CDSA Schedule IV Section 17 Methyprylon
UK: MDA Part III Class C Section 1(a) Methyprylone
UN: Psychotropics Schedule IV Methyprylon
Effective 14 Mar 1977, 42 FR 8636 revoked (and renumbered subsequent entries):
7471
Phencyclidine
US: Currently at CSA Schedule II Section e Subsection 4 Phencyclidine
Effective 2 Dec 2013, 78 FR 72013 added (and renumbered subsequent entries):
On 22 Oct 2013, 78 FR 62500 proposed to add (and to renumber subsequent entries):
(11)
2261
Perampanel, and its salts, isomers, and salts of isomers
Tiletamine
Zolazepam
Effective 20 Feb 1987, 52 FR 2221 added:
(15)
7295
Tiletamine (2-(Ethylamino)-2-(2-thienyl)cyclohexanone) and Zolazepam (4-(2-Fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e][1,4]diazepin-7(1H)-one; Flupyrazapon) or any salt thereof
Some trade or other names for a Tiletamine-Zolazepam combination product: Telazol
⇒
PubChem: 26533; ChemSpider: 24714; Bluelight: Tiletamine; Drugs Forum: Tiletamine; Erowid: Tiletamine; Wikipedia: Tiletamine11 March 2016 · 
· Isomer Design
· Isomer Design